Izzo F - Search Results

1

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol.

Avallone A, Piccirillo MC, Di Gennaro E, Romano C, Calabrese F, Roca MS, Tatangelo F, Granata V, Cassata A, Cavalcanti E, Maurea N, Maiolino P, Silvestro L, De Stefano A, Giuliani F, Rosati G, Tamburini E, Aprea P, Vicario V, Nappi A, Vitagliano C, Casaretti R, Leone A, Petrillo A, Botti G, Delrio P, Izzo F, Perrone F, Budillon A. Avallone A, et al. Among authors: izzo f. Ther Adv Med Oncol. 2020 Aug 11;12:1758835920929589. doi: 10.1177/1758835920929589. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32849914 Free PMC article.

2

Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results.

Vallone P, Gallipoli A, Izzo F, Fiore F, Delrio P. Vallone P, et al. Among authors: izzo f. Anticancer Res. 2003 Nov-Dec;23(6D):5075-9. Anticancer Res. 2003. PMID: 14981969 Clinical Trial.

3

Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.

Comella P, Massidda B, Palmeri S, Putzu C, De Rosa V, Izzo F, Fiore F, Casaretti R, Sandomenico C. Comella P, et al. Among authors: izzo f. Anticancer Drugs. 2006 Sep;17(8):985-92. doi: 10.1097/01.cad.0000224452.62071.ce. Anticancer Drugs. 2006. PMID: 16940809 Clinical Trial.

4

Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor.

Izzo F, Piccirillo M, Albino V, Botti G, Foggia M, Iodice R, Pagano F, Piccirillo G, Tornillo L, Delrio P. Izzo F, et al. Eur J Gastroenterol Hepatol. 2010 Jul;22(7):892-4. doi: 10.1097/MEG.0b013e32832eb62b. Eur J Gastroenterol Hepatol. 2010. PMID: 19550345

5

Molecular analysis of Fanconi anemia and mismatch repair genes in patients with colorectal carcinoma.

Colombino M, Avallone A, Izzo F, Tatangelo F, Budroni M, Cossu A, Galimi F, Comella P, Botti G, Sini MC, Tanda F, Palmieri G; Southern Italy Cooperative Oncology Group. Colombino M, et al. Among authors: izzo f. Oncol Rep. 2011 Apr;25(4):899-904. doi: 10.3892/or.2011.1169. Epub 2011 Jan 31. Oncol Rep. 2011. PMID: 21286667

6

Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.

Manca A, Sini MC, Izzo F, Ascierto PA, Tatangelo F, Botti G, Gentilcore G, Capone M, Mozzillo N, Rozzo C, Cossu A, Tanda F, Palmieri G. Manca A, et al. Among authors: izzo f. Oncol Rep. 2011 Jun;25(6):1495-502. doi: 10.3892/or.2011.1220. Epub 2011 Mar 18. Oncol Rep. 2011. PMID: 21424129

7

Can hepatocellular carcinoma (HCC) produce unconventional metastases? Four cases of extrahepatic HCC.

Piccirillo M, Granata V, Albino V, Palaia R, Setola SV, Petrillo A, Tatangelo F, Botti G, Foggia M, Izzo F. Piccirillo M, et al. Among authors: izzo f. Tumori. 2013 Jan-Feb;99(1):e19-23. doi: 10.1177/030089161309900127. Tumori. 2013. PMID: 23549015

8

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.

Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Tornesello ML, et al. Among authors: izzo f. Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Epub 2013 Apr 11. Genomics. 2013. PMID: 23583669 Free article. Review.

9

Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.

Izzo F, Piccirillo M, Albino V, Palaia R, Belli A, Granata V, Setola S, Fusco R, Petrillo A, Orlando R, Tosone G, Scordino F, Curley SA. Izzo F, et al. HPB (Oxford). 2013 Dec;15(12):985-90. doi: 10.1111/hpb.12080. Epub 2013 Apr 22. HPB (Oxford). 2013. PMID: 23607636 Free PMC article.

10

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F. Lastoria S, et al. Among authors: izzo f. J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17. J Nucl Med. 2013. PMID: 24136935 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page